Skip to main content


HHS Nominee Tom Price Targeted Panel That Urged Fewer Cancer Screenings

By ProPublica  
   February 01, 2017

After a task force of experts said evidence didn't support some cancer screenings, it became the target of lawmakers, including Price and others with health industry ties.

This article first appeared February 3, 2017 on ProPublica.

By Marshall Allen

This story was co-published with NPR's Shots blog.

If the last few years are any guide, one group that may find itself in the crosshairs of Rep. Tom Price, President Trump's pick to lead the Department of Health and Human Services, is an influential panel of medical experts.

The U.S. Preventative Services Task Force, a group of mostly physician and academics from top universities, reviews medical practices to see whether they are supported by research and evidence.

Under the Affordable Care Act, the group's recommendations have been used to guide private insurers. If the group gives a test high marks, insurers are required to cover it. If it doesn't, they are free not to.

ProPublica is an independent, non-profit newsroom that produces investigative journalism in the public interest.

Get the latest on healthcare leadership in your inbox.